Episode: 86 - PANEL DISCUSSION: Near-Term Challenges for ML/AI in Biotherapeutic R&D

About this episode

A panel of industry experts discusses the deployment of AI and machine learning in biologics R&D at PEGS Boston.

At this year’s PEGS Boston, industry experts gathered on a panel to explore how AI and machine learning are deployed in biologics R&D today. Moderated by Peter M. Tessier, Ph.D., Albert M. Mattocks professor of pharmaceutical sciences and chemical engineering at University of Michigan, the panel consisted of Andrew Buchanan, Ph.D., head of discovery at a stealth-mode biotech company; Norbert Furtmann, Ph.D., head of biologics AI and design of large molecules research at Sanofi; Konrad S. ...

People in this episode

Host: Peter M. Tessier, Ph.D.

Guests: Andrew Buchanan, Ph.D., Norbert Furtmann, Ph.D.

Topics covered

• AI in biotherapeutics
• machine learning
• biologics R&D
• panel discussion
• industry challenges

Keywords

• AI
• machine learning
• biologics
• R&D
• biotherapeutics
• panel discussion
• industry experts

Mentioned in this episode

Organizations: University of Michigan, Sanofi

More episodes of The Chain: Protein Engineering Podcast

• Episode: 85 - Daniel Chen on Building Multi-Target Drugs with Logic Gating · May 12, 2026 · 47 min
• Episode: 84 - Martin Pacesa on BindCraft: An Automated Pipeline for De Novo Protein Binder Design · April 15, 2026 · 39 min
• Episode: 83 - Patrick Baeuerle and Jeffrey Miller on T Cell and Immune Cell Engagement · March 17, 2026 · 59 min
• Episode: 82 - PANEL DISCUSSION: Future of Biologic Therapeutics: Will Half-Life Extended Peptides Replace Multispecific Antibodies? · February 10, 2026 · 49 min
• Episode: 81 - Laszlo Radvanyi on Pushing Boundaries in Cancer Immunotherapy Research · January 13, 2026 · 44 min
• Episode: 80 - Vibha Jawa Discusses the Impact of Biologic Molecules and the Future of Immunogenicity · December 9, 2025 · 27 min